A detailed history of Financial Counselors Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Financial Counselors Inc holds 9,032 shares of BSX stock, worth $812,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,032
Previous 9,002 0.33%
Holding current value
$812,880
Previous $693,000 9.09%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $2,188 - $2,520
30 Added 0.33%
9,032 $756,000
Q2 2024

Aug 01, 2024

SELL
$67.33 - $77.71 $6,733 - $7,770
-100 Reduced 1.1%
9,002 $693,000
Q1 2024

May 02, 2024

SELL
$57.6 - $68.62 $3,456 - $4,117
-60 Reduced 0.65%
9,102 $623,000
Q4 2023

Jan 26, 2024

BUY
$48.64 - $57.81 $18,531 - $22,025
381 Added 4.34%
9,162 $529,000
Q3 2023

Nov 07, 2023

BUY
$50.19 - $54.68 $150 - $164
3 Added 0.03%
8,781 $463,000
Q2 2023

Jul 27, 2023

SELL
$49.72 - $54.64 $10,093 - $11,091
-203 Reduced 2.26%
8,778 $475,000
Q1 2023

May 02, 2023

BUY
$45.09 - $50.03 $5,275 - $5,853
117 Added 1.32%
8,981 $449,000
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $13,133 - $15,677
-332 Reduced 3.61%
8,864 $410,000
Q3 2022

Nov 01, 2022

SELL
$36.71 - $109.66 $1,431 - $4,276
-39 Reduced 0.42%
9,196 $356,000
Q2 2022

Aug 02, 2022

SELL
$35.24 - $47.1 $37,742 - $50,444
-1,071 Reduced 10.39%
9,235 $344,000
Q1 2022

Apr 28, 2022

BUY
$40.9 - $45.1 $35,705 - $39,372
873 Added 9.25%
10,306 $456,000
Q4 2021

Feb 10, 2022

SELL
$38.07 - $44.87 $34,986 - $41,235
-919 Reduced 8.88%
9,433 $401,000
Q3 2021

Oct 26, 2021

BUY
$41.23 - $45.88 $1,607 - $1,789
39 Added 0.38%
10,352 $449,000
Q2 2021

Aug 03, 2021

SELL
$38.58 - $44.24 $38,271 - $43,886
-992 Reduced 8.77%
10,313 $441,000
Q1 2021

Apr 29, 2021

SELL
$35.27 - $39.67 $9,699 - $10,909
-275 Reduced 2.37%
11,305 $437,000
Q4 2020

Feb 10, 2021

BUY
$33.15 - $41.97 $3,381 - $4,280
102 Added 0.89%
11,580 $416,000
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $206,398 - $253,084
-5,993 Reduced 34.3%
11,478 $439,000
Q2 2020

Aug 07, 2020

BUY
$30.19 - $39.11 $191,948 - $248,661
6,358 Added 57.21%
17,471 $613,000
Q1 2020

Apr 23, 2020

BUY
$25.83 - $45.71 $7,852 - $13,895
304 Added 2.81%
11,113 $363,000
Q4 2019

Jan 31, 2020

SELL
$37.87 - $45.37 $1,893 - $2,268
-50 Reduced 0.46%
10,809 $489,000
Q1 2019

May 10, 2019

BUY
$32.91 - $40.75 $127,262 - $157,580
3,867 Added 55.31%
10,859 $417,000
Q4 2018

Feb 01, 2019

SELL
$31.73 - $39.04 $3,966 - $4,880
-125 Reduced 1.76%
6,992 $247,000
Q3 2018

Oct 30, 2018

SELL
$32.83 - $38.63 $6,533 - $7,687
-199 Reduced 2.72%
7,117 $274,000
Q2 2018

Aug 03, 2018

SELL
$26.84 - $34.32 $5,368 - $6,864
-200 Reduced 2.66%
7,316 $239,000
Q1 2018

Apr 26, 2018

BUY
$25.2 - $28.54 $189,403 - $214,506
7,516 New
7,516 $205,000
Q4 2017

Feb 12, 2018

SELL
$24.79 - $29.8 $193,758 - $232,916
-7,816 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $7,300 - $8,109
278 Added 3.69%
7,816 $228,000
Q2 2017

Aug 10, 2017

BUY
N/A
7,538
7,538 $209,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.